CoChat
Sign Up
Cited by 856Traditional Chinese Medicine StudiesComplementary and Alternative Medicine StudiesHistory of Medicine Studies

Ayurveda and Traditional Chinese Medicine: A Comparative Overview

Open access
Patwardhan, Bhushan, Warude, Dnyaneshwar, Pushpangadan, P., Bhatt, Narendra·2005·Evidence-Based Complementary and Alternative Medicine
DOI 10.1093/ecam/neh140PMC PMC1297513
Open this paper in CoChat — free accountOpen PDF

Abstract

Ayurveda, the traditional Indian medicine (TIM) and traditional Chinese medicine (TCM) remain the most ancient yet living traditions. There has been increased global interest in traditional medicine. Efforts to monitor and regulate herbal drugs and traditional medicine are underway. China has been successful in promoting its therapies with more research and science‐based approach, while Ayurveda still needs more extensive scientific research and evidence base. This review gives an overview of basic principles and commonalities of TIM and TCM and discusses key determinants of success, which these great traditions need to address to compete in global markets.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ecam/neh140

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In public and policy discourse in India, Chinese medicine's success in the global market is largely attributed to its 'progressive,' 'science-based approach,' a model that Ayurvedic stakeholders are urged to follow.

    “In public and policy discourse in India, Chinese medicine's success in the global market is largely attributed to its 'progressive,' 'science-based approach,' a model that Ayurvedic stakeholders are urged to follow.”

    From Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market (2019) · cites this paper as Patwardhan et al. 2005

    The Conclusion says China promoted its therapies with scientific evidence acceptable globally and urges India to draw on TCM examples in policy and research. The Government Policies section also describes science-based approaches in TCM education. These passages support the proposed model for Ayurveda, but do not establish that this explanation predominates in Indian public and policy discourse. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 48

  1. [2]Legal status of traditional medicine, complementary/alternative medicine: a worldwide review 2001 Geneva World Health Organization
  2. [3]Seidl PR Pharmaceuticals from natural products: current trends An Acad Bras Cienc 2002 74 145 50 11960183
  3. [6]Jiang Y Wang Y Yan X Chinese pharmaceutical companies: an emerging industry Drug Discov Today 2000 6 610 2 11408192
  4. [10]Fabricant DS Farnsworth NR The value of plants used in traditional medicine for drug discovery Environ Health Perspect 2001 109 69 75 11250806 PMC1240543
  5. [11]Maggon K Best selling human medicine 2002–2004 Drug Discov Today 2005 11 739 42 15922927
  6. [12]World Health Organization Report of the inter-regional workshop on intellectual property rights in the context of traditional medicine, Bangkok, Thailand, Dec 6–8, 2000
  7. [13]Bodekar G Kronenberg F A public health agenda for complementary, alternative and traditional (indigenous) medicine Am J Public Health 2002 92 1582 91 12356597 PMC3221447
  8. [14]De Smet PA Herbal remedies New Engl J Med 2002 347 2046 56 12490687
  9. [16]Handa SS Indian efforts for quality control and standardization of herbal drugs/products 2004 Proceedings of the 1st joint workshop on quality control and standardization of traditional medicine—Indo-China experience Jan 8–10, 2004
  10. [19]Cooper EL CAM, eCAM, bioprospecting: the 21st century pyramid Evid Based Complement Alternat Med 2005 2 125 7 15937551 PMC1142206
  11. [20]Gavaghan H Koop may set up new center for alternative medicine Nature 1994 370 591 8065440
  12. [22]Gibert TF Reflections on traditional Chinese medicine and its pharmacopoeia Ann Pharm Fr 1998 56 282 5 9872017
  13. [23]Cheng JT Review: drug therapy in Chinese traditional medicine J Clin Pharmacol 2000 40 445 50 10806595
  14. [24]Hankey A CAM modalities can stimulate advances in theoretical biology Evid Based Complement Alternat Med 2005 2 5 12 15841271 PMC1062166
  15. [25]Lad V The human constitution Ayurveda: The Science of Self-Healing 1985 Wilmot Lotus Press 26 36
  16. [26]Cardellina JH Challenges and opportunities confronting the botanical dietary supplement industry J Nat Prod 2002 65 1073 84 12141880
  17. [27]Marccus DM Grollman AP Botanical medicines—the need for new regulations New Engl J Med 2002 347 2073 6 12490692
  18. [33]Saper RB Kales SN Paquin J Burns MJ Eisenberg DM Davis RB Phillips RS Heavy metal content of ayurvedic herbal medicine products J Am Med Assoc 2004 292 2868 73 15598918
  19. [34]Ernst E Toxic heavy metals and undeclared drugs in Asian herbal medicines Trends Pharmacol Sci 2002 23 136 9 11879681
  20. [37]Sharma DC India raises standards for traditional drugs Lancet 2000 356 231 10963211
  21. [45]Diwanay S Gautam M Patwardhan B Cytoprotection and immunomodulation in cancer therapy Curr Med Chem Anti-Canc Agents 2004 4 479 90 15579014
  22. [46]Patwardhan B Gautam M Botanical immunodrugs: scope and opportunities Drug Discov Today 2005 7 495 502 PMC7128543 15809195
  23. [47]Normile D The new face of traditional Chinese medicine Science 2003 299 188 90 12522228
  24. [49]Tang JL Zhan SY Ernst E Review of randomized controlled trials of traditional Chinese medicine Br Med J 1999 319 160 1 10406751 PMC28166
  25. [50]Cao Y Shi Y Zheng Y Shi M Lo SK Blood-nourishing and hard-softening capsule costs less in the management of osteoarthritic knee pain: a randomized controlled trial Evid Based Complement Alternat Med 2005 2 363 8 16136214 PMC1193545
  26. [51]Nelson R FDA issues alert on ephedra supplements in the USA Lancet 2004 363 135 14733193
  27. [52]Fong KCS Kinnear PE Gingko biloba and retrobulbar hemorrhage following peribulbar local anesthetic injection for cataract surgery Postgrad Med J 2003 79 531 2 13679551 PMC1742835
  28. [54]Ammon HP Safayhi H Mack T Sabieraj J Mechanism of anti-inflammatory actions of curcumin and boswellic acids J Ethnopharmacol 1993 38 113 9 8510458
  29. [56]Dwivedi Y Rastogi R Garg NK Dhawan BN Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats Pharmacol Toxicol 1992 71 383 7 1333078
  30. [57]Visen PK Shukla B Patnaik GK Dhawan BN Andrographolide protects rat hepatocytes against paracetamol-induced damage J Ethnopharmacol 1993 40 131 6 8133653
  31. [58]Johri RK Zutshi U Mechanism of action of 6,7,8,9,10,12-hexahydro-azepino-[2,1-b]quinazolin-12-one-(RLX)—a novel bronchodilator Indian J Physiol Pharmacol 2000 44 75 81 10919099
  32. [59]Bhatt AD Clinical trials of Ayurvedic medicine: myths, realities and challenges J Assoc Physicians India 2001 49 558 62 11361273
  33. [60]Sekhar AV Gandhi DN Rao NM Rawal UD An experimental and clinical evaluation of anti-asthmatic potentialities of Devadaru compound (DC) Indian J Physiol Pharmacol 2003 47 101 7 12708131
  34. [61]Gupta I Gupta V Parihar A Gupta S Ludtke R Safayhi H Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study Eur J Med Res 1998 3 511 4 9810030
  35. [62]Chopra A Lavin P Patwardhan B Chitre D Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis J Rheumatol 2000 27 1365 72 10852255
  36. [63]Gupta R Singhal S Goyle A Sharma VN Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomized placebo-controlled trial J Assoc Physicians India 2000 49 231 5 11225136
  37. [64]Kumar PU Adhikari P Pereira P Bhat P Safety and efficacy of Hartone in stable angina pectoris—an open comparative trial J Assoc Physicians India 1999 47 685 9 10778587
  38. [66]Atal CK Dubey RK Singh J Biochemical basis of enhanced drug availability by piperine: evidence that piperine is a potent inhibitor of drug metabolism J Pharmacol Exp Ther 1985 232 258 62 3917507
  39. [67]Gautam M Diwanay SS Gairola S Shinde YS Jadhav SS Patwardhan BK Immune response modulation to DPT vaccine by aqueous extract of Withania somnifera in experimental system Int Immunopharmacol 2004 4 841 9 15135324
  40. [68]Gautam M Diwanay S Gairola S Shinde Y Patki P Patwardhan B Immunoadjuvant potential of Asparagus racemosus aqueous extract in experimental system J Ethnopharmacol 2004 91 251 5 15120447
  41. [71]Indian Council of Medical Research Flexible dose open trail of Vijayasar in cases of newly diagnosed non-insulin dependent diabetes mellitus Indian J Med Res 1998 108 24 9 9745215
  42. [72]Khan S Balick MJ Therapeutic plants of ayurveda: a review of selected clinical and other studies for 166 species J Altern Complement Med 2001 7 405 515 11719942
  43. [77]Patwardhan B Joshi K Chopra A Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda J Altern Complement Med 2005 11 349 53 15865503
  44. [80]Farooqi AA Sreeramu BS History, importance, present status and future prospects of medicinal crops Cultivation of Medicinal and Aromatic Crops 2001 Hyderabad Universities press 1 19
  45. [81]Wo Jizhou Thinking about the situation of research on GAP in China 2004 Proceedings of the 1st joint workshop on quality control and standardization of traditional medicine—Indo-China experience Jan 8–10
  46. [84]Pushpangadan P Traditional knowledge & folklore—A benefit-sharing model experimented in India. International conference of commission on intellectual property rights organized by Royal Society 2002 London
  47. [87]Patwardhan B Ayurveda: the ‘designer’ medicine: a review of ethno pharmacology and bioprospecting research Indian Drugs 2000 37 213 27
  48. [89]Vaidya RA Vaidya ADB Patwardhan B Tillu G Rao Y Ayurvedic pharmacoepidemiology: a proposed new discipline J Assoc Physicians India 2003 51 528 12974443

Cited by

Sorted by citations

Authors
Patwardhan, B., Warude, D., Pushpangadan, P., & Bhatt, N.
Affiliations
  • Savitribai Phule Pune University (IN)
  • National Botanical Research Institute (IN)
Corresponding author
Patwardhan, Bhushan
ORCID
Venue
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Published
2005-01
Volume
2
Issue
4
Pages
465-473
ISSN
  • 1741-427X (ISSN-L)
  • 1741-4288
DOI
10.1093/ecam/neh140
PMC
PMC1297513
OpenAlex
W2150124540
Cited by
856
References
0
Citations by year
2026: 68 · 2025: 72 · 2024: 54 · 2023: 70 · 2022: 49 · 2021: 55 · 2020: 40 · 2019: 51 · 2018: 38 · 2017: 33 · 2016: 32 · 2015: 36 · 2014: 36 · 2013: 32 · 2012: 37
FWCI
29.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Evidence-based Complementary and Alternative Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University Grants Commission
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Social Sciences › Arts and Humanities › History › History of Medicine Studies
Keywords
Ayurveda, traditional Chinese medicine, traditional Indian medicine, comparative medicine, herbal drugs, traditional medicine regulation, evidence base, global market competitiveness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review